Completed NA INTERVENTIONAL 2-arm NCT01326949

Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis

Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Treatment Combined With Propranolol for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis: A Randomized Controlled Trial

Sponsor: Air Force Military Medical University, China

Conditions Bleeding Varices Decompensated Cirrhosis Portal Vein Thrombosis

Interventions ET+NSBB Transjugular intrahepatic portosystemic shunt (TIPS)

Updated 7 times since 2017 Last updated: May 18, 2017 Started: May 31, 2011 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Bleeding Varices and Decompensated Cirrhosis, this trial is completed. The trial is conducted by Air Force Military Medical University, China and has accumulated 7 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2020 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Nov 2020 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Jun 2017 [monthly]

Completed NA

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Air Force Military Medical University, China

Data source: Air Force Military Medical University, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xi'an, China